Skip to content

Morphine effects in in patients with abdominal pain

Effects of Morphine analgesia on diagnostic accuracy of abdominal pain

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015092224128N1
Enrollment
200
Registered
2015-12-26
Start date
2014-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute abdomen. Pain localized to upper abdomen

Interventions

Intervention 1: Administration of 0.1 mg/kg Morphine Sulfate (Darou Pakhsh, Iran) in the study group. Intervention 2: Administration of normal saline in equal volume of Morphine Sulfate 0.1 mg/kg as a
Diagnosis
Administration of 0.1 mg/kg Morphine Sulfate (Darou Pakhsh, Iran) in the study group
Administration of normal saline in equal volume of Morphine Sulfate 0.1 mg/kg as a placebo in the control group

Sponsors

Vice chancellor, Birjand University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Any patient with acute abdominal pain Exclusion criteria: Patients less than 18 years old; Pregnancy; Patients with the history of abdominal pain more than 3 days; Hypotension (blood pressure less than 90 mmHg); Traumatic patients; Patients with a history of allergy to morphine and its derivatives

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Disease diagnosis. Timepoint: Two hours after intervention. Method of measurement: Physical examination.

Secondary

MeasureTime frame
No secondary outcome measure. Timepoint: -. Method of measurement: -.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahtab Ghaemi

Birjand University of Medical Sciences

ghaemim881@gmail.com+98 51 3842 4981

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026